Echinomycin mitigates ocular angiogenesis by transcriptional inhibition of the hypoxia-inducible factor-1
Open Access
- 1 May 2021
- journal article
- research article
- Published by Elsevier in Experimental Eye Research
- Vol. 206, 108518
Abstract
No abstract availableKeywords
Funding Information
- Karolinska Institutet
- Gobierno de Espana Ministerio de Ciencia Innovacion y Universidades
- Ögonfonden
- Erasmus+
This publication has 42 references indexed in Scilit:
- Initial non-responders to ranibizumab in the treatment of age-related macular degeneration (AMD)Clinical Ophthalmology, 2013
- Projected prevalence of age‐related macular degeneration in Scandinavia 2012–2040Acta Ophthalmologica, 2012
- A Computational Tool for Quantitative Analysis of Vascular NetworksPLOS ONE, 2011
- Enhancement of differentiation efficiency of hESCs into vascular lineage cells in hypoxia via a paracrine mechanismStem Cell Research, 2011
- Physical and functional interactions between Runx2 and HIF-1α induce vascular endothelial growth factor gene expressionJournal of Cellular Biochemistry, 2011
- Neovascular age‐related macular degeneration: too many theories, too little knowledge?Acta Ophthalmologica, 2008
- Biology of HIF-1αCell Death & Differentiation, 2008
- Expression of hypoxia-inducible factor 1 and 2 in choroidal neovascular membranes associated with age-related macular degenerationBritish Journal of Ophthalmology, 2007
- Hypoxia-dependent activation of HIF into a transcriptional regulatorSeminars in Cell & Developmental Biology, 2005
- Purification and Characterization of Hypoxia-inducible Factor 1Journal of Biological Chemistry, 1995